Advancing sarcoma research through artificial intelligence and deep learning
Start Making PredictionsMGB SarcomaAI is at the forefront of combining advanced artificial intelligence with clinical expertise to improve outcomes for sarcoma patients. Our platform leverages state-of-the-art deep learning techniques to provide valuable prognostic information, supporting healthcare professionals in their decision-making process.
Predicts survival probabilities for patients with undifferentiated pleomorphic sarcoma (UPS).
Learn More →Predicts survival probabilities for patients with synovial sarcoma.
Learn More →Predicts survival probabilities for patients with myxofibrosarcoma (MFS).
Learn More →